• About
• Latest Posts
• Latest Blog Posts
• Boards Posted On
• Boards Moderating

ohm20

Send Private Message

Follow Member

Block Messages

Ignore This User

Displaying 1-50 of 6115 result(s).

Board Name	Posts By ohm20	Post Created
CYDY CytoDyn Inc	Leronlimab lowers CTCs very early d (12)	10/16/2025 3:14:44 PM
CYDY CytoDyn Inc	Oops, it would be testing every 2 w (12)	10/16/2025 9:18:38 AM
CYDY CytoDyn Inc	But maybe they decided to look only (6)	10/16/2025 8:25:06 AM
CYDY CytoDyn Inc	Someone also speculated that the 16 (3)	10/15/2025 8:14:57 PM
CYDY CytoDyn Inc	Actually , FDA always want the best (9)	10/15/2025 6:29:44 PM
CYDY CytoDyn Inc	OK , fine , but do you not agree wi (15)	10/15/2025 6:24:54 PM
CYDY CytoDyn Inc	So treatment should be given when n (8)	10/15/2025 6:14:22 PM
CYDY CytoDyn Inc	Yes some patients with mTNBC were v (2)	10/15/2025 6:02:45 PM
CYDY CytoDyn Inc	The Data Safety Management Board ca (12)	10/15/2025 5:54:47 PM
CYDY CytoDyn Inc	But as our trial is design now , we (9)	10/15/2025 5:36:33 PM
CYDY CytoDyn Inc	In mTNBC about 76% of patients died (10)	10/15/2025 5:26:08 PM
CYDY CytoDyn Inc	Personally I am very worry what wil (22)	10/15/2025 3:55:18 PM
CYDY CytoDyn Inc	Does that make it company endorsed (9)	10/15/2025 3:31:57 PM
CYDY CytoDyn Inc	Interesting interview with Dr. Patr (20)	10/11/2025 1:40:38 AM
CYDY CytoDyn Inc	The new research, though, highlight (17)	10/10/2025 3:48:48 AM
CYDY CytoDyn Inc	Is esophageal cancer a likely candi (21)	10/08/2025 11:22:21 PM
CYDY CytoDyn Inc	With only 19,000 potential patients (20)	10/07/2025 8:05:39 AM
CYDY CytoDyn Inc	I will remind you that we still hav (7)	10/05/2025 4:16:12 PM
CYDY CytoDyn Inc	I don't know him, but I have listen (17)	10/05/2025 3:27:11 PM
CYDY CytoDyn Inc	It’s Nader. In regards to the com (9)	10/05/2025 3:09:17 PM
CYDY CytoDyn Inc	I agree that DJL is qualified from (11)	10/05/2025 2:52:25 PM
CYDY CytoDyn Inc	If he solely wanted to help people (17)	10/05/2025 2:32:02 PM
CYDY CytoDyn Inc	As mentioned, the positive aspects (9)	10/05/2025 7:02:20 AM
CYDY CytoDyn Inc	Not only should our CEO be competen (24)	10/05/2025 6:57:03 AM
CYDY CytoDyn Inc	I know that many here would not wan (8)	10/05/2025 6:43:12 AM
CYDY CytoDyn Inc	I was told that Dr. BP "loves Dr. J (7)	10/05/2025 6:39:00 AM
CYDY CytoDyn Inc	Additionally, Dr. BP would have use (8)	10/05/2025 6:26:16 AM
CYDY CytoDyn Inc	Ohm: I just thought of another ques (8)	10/03/2025 12:06:05 PM
CYDY CytoDyn Inc	Ohm: Once LL gets FDA approval for (10)	10/03/2025 12:02:09 PM
CYDY CytoDyn Inc	1. Would a much, much larger basket (19)	10/03/2025 4:28:01 AM
CYDY CytoDyn Inc	Any thoughts as to why Quest would (8)	10/02/2025 3:35:09 PM
CYDY CytoDyn Inc	On the internet one may find this v (14)	10/02/2025 7:24:46 AM
CYDY CytoDyn Inc	We are curious how our company will (13)	10/02/2025 7:16:42 AM
CYDY CytoDyn Inc	Rough calculation Start with 100 mC (22)	10/02/2025 7:01:11 AM
CYDY CytoDyn Inc	I thought this didn't happen until (16)	10/02/2025 5:26:19 AM
CYDY CytoDyn Inc	I have always wondered why Leronlim (11)	10/02/2025 5:03:47 AM
CYDY CytoDyn Inc	The second is that a plethora of fu (15)	10/02/2025 4:44:35 AM
CYDY CytoDyn Inc	This is only regarding the PD-L1 ex (21)	10/02/2025 4:37:15 AM
CYDY CytoDyn Inc	So what would you do if you were Dr (11)	10/02/2025 3:40:54 AM
CYDY CytoDyn Inc	So in your opinion, Plotinus, what (15)	10/01/2025 4:02:10 PM
CYDY CytoDyn Inc	Insurance will not allow it. Hospit (10)	10/01/2025 3:37:01 PM
CYDY CytoDyn Inc	How often are nonexclusive licensin (5)	10/01/2025 3:25:56 PM
CYDY CytoDyn Inc	But if this article is saying, the (11)	09/30/2025 3:20:26 PM
CYDY CytoDyn Inc	∼18% of patients with mTNBC treat (7)	09/30/2025 1:00:02 AM
CYDY CytoDyn Inc	I'm doubtful the rollover protocol (3)	09/29/2025 9:42:02 PM
CYDY CytoDyn Inc	I believe 3 out of 5 patients showe (6)	09/29/2025 6:27:55 PM
CYDY CytoDyn Inc	A new investment vehicle to buy int (4)	09/29/2025 6:21:34 PM
CYDY CytoDyn Inc	Might that be the reason the FDA wo (12)	09/29/2025 6:12:05 PM
CYDY CytoDyn Inc	Plus, the judge was surprised how m (4)	09/29/2025 5:43:16 PM
CYDY CytoDyn Inc	"It's really tragic," Tween said Fr (14)	09/29/2025 5:40:12 PM

• Next >

67967666796611679658567965176796510679650967965046796500679649867964936796487679647567964686795416679510367947226794212679382467938136793808679380567937986793766679376567937596793750679373567934316793429679322367931616792858679285167928496792812679281167928086792806679280267927396792723679272167923436792029679200667919906791989679198667919776791976

Recent Articles

• Karyopharm Therapeutics: Earnings Speculation Ahead
• L.B. Foster Earnings Report Insights and Expectations
• Key Insights Ahead of BRC Inc's Earnings Announcement
• Denny's Expected Earnings: Investment Insights and Trends
• Insightful Earnings Forecast for Medifast Inc This Quarter
• Superior Group of Companies Earnings Insights Before Release
• Recent Equity Grant by INOVIO Enhances Employee Commitment
• Summit Hotel Properties Announces Robust Dividend Strategy Now
• Cellectis Plans Financial Update Release for Q3 Results
• Neuronetics Expands Workforce with Inducement Grants for Growth
• Edesa Biotech's Conference Participation Plans Unveiled
• Vor Bio Implements New Stock Options for Employee Induction
• Global Helium Corp. Completes Go-Private Transaction Successfully
• Teva's Insightful Participation at Upcoming Healthcare Conferences
• TeraWulf's Upcoming Q3 Earnings Call Schedule and Insights
• AMSC Plans Exciting Financial Update for Q2 FY 2025 Soon
• Unitil's Strategic Acquisition Enhances Natural Gas Operations
• Middlesex Water Company: Solid Growth Continues in 2025
• Teva Pharmaceutical's Upcoming Presentations for Investors
• Significant Developments in 1847 Holdings' Legal Matters
• AMSC Prepares to Release Financial Results and Future Outlook
• The Growth of Morningstar Over Two Decades: A Remarkable Journey
• Mastercard's 15-Year Stock Growth: $1000 Investment Insights
• Berkshire Hathaway Reports Significant Gains From Apple Investments
• Comcast's Broadband Challenges Spark Analyst Downgrades
• Middlesex Water Company Achieves Growth and Dividend Increase
• Clover Health's Board Transition: Chelsea Clinton Exits
• Revamping Construction Operations with Modern ERP Solutions
• ECARX Welcomes New Board Member to Enhance Leadership Team
• Revolutionizing K-12 Tech Support: Discover SPARK Today
• Taitron Components Declares Quarterly Cash Dividend for 2025
• Understanding John Hancock Tax-Advantaged Dividend Income Fund
• Assessing FormFactor Inc's Stock Performance and Valuation
• Exploring John Hancock Premium Dividend Fund's Latest Distribution Strategy
• Whale Investors Show Strong Interest in Alcoa Options Trades
• LONGINES Welcomes New York City with Jennifer Lawrence at SoHo
• Deep Insights into Whales' Options Trading for FICO
• Oracle Sees Bullish Options Trends Among Investors
• Aberdeen Investments Shows Commitment with Latest Distribution Details
• Neuberger Berman Declares Monthly Distribution for NRO Shares
• Neuberger Berman Fund Declares Monthly Dividend for Investors
• Neuberger Berman Energy Fund Declares Monthly Dividend Distribution
• Neuberger Berman's Monthly Distribution Highlights for Investors
• Moderna (MRNA) Stock Update: Key Developments and Insights
• Understanding Short Interest Trends for AbbVie Inc Stocks
• Market Sentiment Analysis on Bank of New York Mellon Corp
• Significant Growth of a $1000 Investment in Insmed Over a Decade
• Understanding Palantir Technologies Inc's Current Short Interest
• Tech Titans Continue Dominating Market Trends Amid Economic Shifts
• Investors Anticipate Earnings from Centerspace (CSR)